We and others have demonstrated that osteoprotegerin (OPG), a decoy receptor of Receptor Activator for Nuclear Factor κB Ligand (RANKL) produced by osteoblasts, could decrease joint cartilage degradation in a murine model of joint instability [10], [11]. This evidence concerns the gene TNFSF11 and arthropathy.